IDELVION (CSL Behring Recombinant Facility AG)
Welcome to the PulseAid listing for the IDELVION drug offered from CSL Behring Recombinant Facility AG. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | CSL Behring Recombinant Facility AG |
| NON-PROPRIETARY NAME: | Coagulation Factor IX Recombinant Human |
| SUBSTANCE NAME: | |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2016-03-04 |
| END MARKETING DATE: | 0000-00-00 |
IDELVION PLASMA DERIVATIVE Details:
| Item Description | IDELVION from CSL Behring Recombinant Facility AG |
| LABELER NAME: | CSL Behring Recombinant Facility AG |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2016-03-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69911-864_eb16658d-1ea5-474b-b720-e64b1e61307e |
| PRODUCT NDC: | 69911-864 |
| APPLICATION NUMBER: | BLA125582 |